LungLife AI logo

LungLife AI

LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analysis of biomarkers in blood.

16 employees · est. 2006 · Thousand Oaks, United States

VS
Mainz Biomed logo

Mainz Biomed

Saving lives through innovative molecular diagnostic solutions.

30 employees · est. 2021 · Mainz, Germany

LungLife AI is the older company (2006 vs 2021).

Side-by-Side Comparison

LungLife AI Mainz Biomed
Founded
2006 older 2021
Headquarters
Thousand Oaks, United States Mainz, Germany
Employees
16 30
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
$56.24M $77.50M
Funding Rounds
13 3
Services
Not tracked yet Autonomous Drone Platform, Perimeter Defense & Counter-UAS, Autonomous Demining Systems, Quantum Antenna Technology
Target Customers
Not tracked yet Defense Contractors, Military Organizations, Government Defense Departments, Security Agencies
Taxonomy
AI-enabled Diagnostics, Lung Cancer Detection, Clinical Diagnostic Solutions, Biomarker Analysis, Machine Learning Applications, Cancer Biomarkers, Early Cancer Detection, Molecular Diagnostics, Blood-based Tests, Data-driven Healthcare, Startup, Cancer Research Molecular Diagnostics, Genetic Testing, In-vitro Diagnostics, Colorectal Cancer Detection, Pancreatic Cancer Detection, Early Disease Detection, Biomedical Innovation, Diagnostic Solutions, Life-threatening Conditions, Diagnostic Product Development
Website
lunglifeai.com mainzbiomed.com
LungLife AI logo

About LungLife AI

LungLife AI is a biotechnology startup based in the United States, founded in 2006. The company is dedicated to transforming lung cancer diagnosis and management through AI-enabled analysis of biomarkers in blood. LungLife's diagnostic solutions aim to significantly impact the early detection of lun...

Mainz Biomed logo

About Mainz Biomed

Mainz Biomed, founded in 2021 and headquartered in Germany, is a biotech company focused on revolutionizing health care through its innovative molecular diagnostic solutions. With the slogan "Saving lives through innovative molecular diagnostic solutions," the company is dedicated to developing user...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at LungLife AI and Mainz Biomed — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at LungLife AI and Mainz Biomed — by email.

Frequently Asked Questions

LungLife AI — LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analysis of biomarkers in blood.. Mainz Biomed — Saving lives through innovative molecular diagnostic solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
LungLife AI has raised $56.24M while Mainz Biomed has raised $77.50M.
LungLife AI and Mainz Biomed operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare LungLife AI with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy